The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA
Open accessAbstract
RNA-guided endonucleases (RGENs) derived from the CRISPR/Cas system represent an efficient tool for genome editing. RGENs consist of two components: Cas9 protein and guide RNA. Plasmid-mediated delivery of these components into cells can result in uncontrolled integration of the plasmid sequence into the host genome, and unwanted immune responses and potential safety problems that can be caused by the bacterial sequences. Furthermore, this delivery method requires transfection tools. Here we show that simple treatment with cell-penetrating peptide (CPP)-conjugated recombinant Cas9 protein and CPP-complexed guide RNAs leads to endogenous gene disruptions in human cell lines. The Cas9 protein was conjugated to CPP via a thioether bond, whereas the guide RNA was complexed with CPP, forming condensed, positively charged nanoparticles. Simultaneous and sequential treatment of human cells, including embryonic stem cells, dermal fibroblasts, HEK293T cells, HeLa cells, and embryonic carcinoma cells, with the modified Cas9 and guide RNA, leads to efficient gene disruptions with reduced off-target mutations relative to plasmid transfections, resulting in the generation of clones containing RGEN-induced mutations. Our CPP-mediated RGEN delivery process provides a plasmid-free and additional transfection reagent-free method to use this tool with reduced off-target effects. We envision that our method will facilitate RGEN-directed genome editing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“RNP electroporation exhibits higher on-target editing efficiency and lower off-target mutations than the other delivery methods”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Ramakrishna et al., 2014
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A powerful advantage of the CRISPR/Cas9 system is the ability to target any ∼23-bp sequence that contains a PAM motif on either strand of DNA.”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Ramakrishna et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“cell-penetrating peptides (CPP), conjugated with Cas9 and complexed with gRNA enabled efficient gene silencing in human cell lines and disease models featuring fewer off-target effects when compared to plasmid transfection [153,154].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [153]
Experimental — accuracy not yet measuredIn the citing paper
“Ramakrishna et al. demonstrated that conjugating Cas9 and sgRNA with cell-penetrating peptides (CPPs) enhanced intracellular delivery efficiency because of the membrane-disturbed properties of CPPs.[227]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [227]
In the citing paper
“Some work with CPPs and CRISPR/Cas9 was accomplished as early as 2014 by Ramakrishna et al. (2014), who showed separate delivery of CPP–Cas9 and CPP–sgRNA to multiple human cell lines.”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Ramakrishna et al., 2014
In the citing paper
“Ramakrishna et al. developed cell-penetrating peptide (CPP)-conjugated recombinant Cas9 protein and CPP-complexed guide RNAs for gene disruptions of CCR5 locus in human cell lines, including HEK293T, HeLa, NCCIT (a human pluripotent embryonal carcinoma cell line), human dermal fibroblasts and human embryonic stem cells.”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [96]
In the citing paper
“Cell-penetrate-peptide-mediated delivery was reported to achieve higher on-to off-target activity ratio compared with plasmid-mediated delivery.53”
From CRISPR-Cas9: a new and promising player in gene therapy (2015) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 3×
“responses (Hemmi et al. 2000; Wagner 2001) caused by bacterial sequences, and safety problems if the antibiotic-resistance gene is taken up by pathogenic bacteria.”
BackgroundInfluentialDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
CRISPR/Cas, the Immune System of Bacteria and Archaea
Horvath, P., & Barrangou, R. (2010) · Science · doi:10.1126/science.1179555 · Cited by 2,471
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 653
He, C., Chen, B., Yan, C., & Zhou, X. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1612868 · Cited by 16
Kaushal, K., Kim, E., Tyagi, A., Karapurkar, J. K., Haq, S., Jung, H.-S., Kim, K.-S., & Ramakrishna, S. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00956-7 · Cited by 14
Self-citationInhibition of regulated cell death by cell-penetrating peptides
Krautwald, S., Dewitz, C., Fändrich, F., & Kunzendorf, U. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2200-7 · Cited by 14
Toward precise CRISPR DNA fragment editing and predictable 3D genome engineering
Wu, Q., & Shou, J. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa060 · Cited by 15
Epigenetic targeting for lung cancer treatment via CRISPR/Cas9 technology
Khajuria, O., & Sharma, N. (2021) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2021.100012 · Cited by 14
Farcaș, A., Janosi, L., & Aştilean, S. (2021) · Computational and Theoretical Chemistry · doi:10.1016/j.comptc.2021.113581 · Cited by 14
Chen, H., Li, Y., Du, C., Li, Y., Zhao, J., Zheng, X., Mao, Q., & Xia, H. (2018) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2018.10.011 · Cited by 14
Jeong, T. Y., Yoon, D. E., Kim, S. P., Yang, J., Lim, S., Ok, S. H., Ju, S., Park, J., Lee, S. B., Park, S.-J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58364-7 · Cited by 13
Self-citationNon-Viral CRISPR carriers: transient delivery with lasting effects
Lummerstorfer, M., & Lächelt, U. (2026) · Drug Delivery · doi:10.1080/10717544.2026.2614125 · Cited by 14
Safe Harbor Targeted CRISPR-Cas9 Tools for Molecular-Genetic Imaging of Cells in Living Subjects
Dubois, V. P., Zotova, D., Parkins, K. M., Swick, C., Hamilton, A. M., Kelly, J. J., & Ronald, J. A. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0030 · Cited by 14
Purified Cas9 Fusion Proteins for Advanced Genome Manipulation
Mircetic, J., Steinebrunner, I., Ding, L., Fei, J., Bogdanova, A. I., Drechsel, D. N., & Buchholz, F. (2017) · Small Methods · doi:10.1002/smtd.201600052 · Cited by 14
Synergistic gene delivery by self-assembled nanocomplexes using fusion peptide and calcium phosphate
Jeong, S. G., Ryu, Y. C., & Hwang, B. H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.034 · Cited by 14
Diaz, J., Pietsch, M., Davila, M., Jaimes, G. A., Hudson, A., & Pellois, J.-P. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00369 · Cited by 13
Robert, M.-A., Lytvyn, V., Deforet, F., Gilbert, R., & Gaillet, B. (2016) · Molecular Biotechnology · doi:10.1007/s12033-016-9987-1 · Cited by 14
Recent advances in DNA-free editing and precise base editing in plants
Zhang, Y., & Gao, C. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170021 · Cited by 16
Takashina, T., Koyama, T., Nohara, S., Hasegawa, M., Ishiguro, A., Iijima, K., Lü, J., Shimura, M., Okamura, T., Sakuma, T., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.040 · Cited by 13
Xu, K., Zhang, X., Liu, Z., Ruan, J., Xu, C., Che, J., Fan, Z., Mu, Y., & Li, K. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2058-2 · Cited by 13
Attempts to implement CRISPR/Cas9 for genome editing in the oomycete Phytophthora infestansPreprint
van den Hoogen, J., & Govers, F. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/274829 · Cited by 13
CRISPR/Cas systems usher in a new era of disease treatment and diagnosis
Li, R., Wang, Q., She, K., Lu, F., & Yang, Y. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00095-y · Cited by 13
Bioorthogonal CRISPR/Cas9‐Drug Conjugate: A Combinatorial Nanomedicine Platform
Beha, M. J., Kim, J., Im, S. H., Kim, Y., Yang, S., Lee, J. H., Nam, Y. R., Lee, H., Park, H., & Chung, H. J. (2023) · Advanced Science · doi:10.1002/advs.202302253 · Cited by 11
RETRACTED ARTICLE: Revolutionizing Lung Cancer Treatment: Innovative CRISPR-Cas9 Delivery Strategies
Singh, D. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02834-6 · Cited by 13
RetractedAnionic polymer coating for enhanced delivery of Cas9 mRNA and sgRNA nanoplexes
Chen, S., Carneiro, S. P., & Merkel, O. M. (2024) · Biomaterials Science · doi:10.1039/d4bm01290a · Cited by 12
CGD: Comprehensive guide designer for CRISPR-Cas systems
Menon, A. V., Sohn, J.-I., & Nam, J. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.03.020 · Cited by 12
Essential cues of engineered polymeric materials regulating gene transfer pathways
Islam, M. A., Park, T., Firdous, J., Li, H.-S., Jiménez-Pérez, Z. E., Lim, M., Choi, J.-W., Yun, C., & Cho, C. (2022) · Progress in Materials Science · doi:10.1016/j.pmatsci.2022.100961 · Cited by 12
Epigenetic Editing in Prostate Cancer: Challenges and Opportunities
Pacheco, M. B., Camilo, V., Henrique, R., & Jerónimo, C. (2021) · Epigenetics · doi:10.1080/15592294.2021.1939477 · Cited by 12
Direct Protein Delivery to Mammalian Cells Using Cell-permeable Cys2-His2 Zinc-finger Domains
Gaj, T., & Liu, J. (2015) · Journal of Visualized Experiments · doi:10.3791/52814 · Cited by 12
Li, Y., Tian, H., Ding, J., Lin, L., Chen, J., Gao, S., & Chen, X. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500165 · Cited by 12
How Crisp is CRISPR? CRISPR-Cas-mediated crop improvement with special focus on nutritional traits
Kaul, T., Sony, S. K., Raman, N. M., Eswaran, M., Verma, R., Prakash, A. T., Bharti, J., Motelb, K. F. A., & Kaul, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818581-0.00011-5 · Cited by 12
Targeted Genome Editing Using DNA-Free RNA-Guided Cas9 Ribonucleoprotein for CHO Cell Engineering
Shin, J., Lee, N., Cho, S., & Cho, B. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7795-6_8 · Cited by 12
Gholamian, S., Baghaee, P., & Doroudian, M. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202400412 · Cited by 15
Strength in numbers: cell penetrating peptide clusters to build next-generation therapeutics
Reeman, J., Ittner, L. M., Vallis, K. A., & Tietz, O. (2024) · Trends in Chemistry · doi:10.1016/j.trechm.2024.09.003 · Cited by 11
Versatile 3′ Functionalization of CRISPR Single Guide RNA
Palumbo, C. M., Gutierrez‐Bujari, J. M., O’Geen, H., Segal, D. J., & Beal, P. A. (2020) · ChemBioChem · doi:10.1002/cbic.201900736 · Cited by 11
CRISPR-Cas9 Genome Editing Tool for the Production of Industrial Biopharmaceuticals
Khan, A. H., Tye, G. J., & Noordin, R. (2020) · Molecular Biotechnology · doi:10.1007/s12033-020-00265-9 · Cited by 11
Insights of CRISPR-Cas systems in stem cells: progress in regenerative medicine
Shanmugam, D. K., Aashabharathi, M., Devi, G. K., Subbaiya, R., & Saravanan, M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06832-w · Cited by 11
Cell-penetrating peptide: A powerful delivery tool for DNA-free crop genome editing
Wu, H., Zhang, K., Zhang, Z., Wang, J., Jia, P., Cong, L., Li, J., Duan, Y., Ke, F., Zhang, F., et al. (2022) · Plant Science · doi:10.1016/j.plantsci.2022.111436 · Cited by 11
Generation of gene-of-interest knockouts in murine organoids using CRISPR-Cas9
Huber, A., Dijkstra, C., Ernst, M., & Eissmann, M. F. (2023) · STAR Protocols · doi:10.1016/j.xpro.2023.102076 · Cited by 14
USP19 Negatively Regulates p53 and Promotes Cervical Cancer Progression
Tyagi, A., Karapurkar, J. K., Colaco, J. C., Sarodaya, N., Antao, A. M., Kaushal, K., Haq, S., Chandrasekaran, A. P., Das, S., Singh, V., et al. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00814-y · Cited by 12
Self-citationMojarrad, M., Qomi, S. B., & Asghari, A. (2019) · Advanced Biomedical Research · doi:10.4103/abr.abr_41_19 · Cited by 12
Small nucleic acids and the path to the clinic for anti-CRISPR
Barkau, C. L., O’Reilly, D., Eddington, S. B., Damha, M. J., & Gagnon, K. T. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114492 · Cited by 12
Kaushal, K., Tyagi, A., Karapurkar, J. K., Kim, E., Tanguturi, P., Kim, K.-S., Jung, H.-S., & Ramakrishna, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020856 · Cited by 11
Self-citationCRISPR/Cas-based Human T cell Engineering: Basic Research and Clinical Application
Bernard, B. E., Landmann, E., Jeker, L. T., & Schumann, K. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.03.005 · Cited by 12
Saponin and fluorine-modified polycation as a versatile gene delivery system
Hasanzadeh, A., Vahabi, A. H., Hooshmand, S. E., Hosseini, E. S., Azar, B. K. Y., Kiani, J., Saeedi, S., Shahbazi, A., Rudra, A., Hamblin, M. R., et al. (2022) · Nanotechnology · doi:10.1088/1361-6528/ac842d · Cited by 10
Kapelner, R. A., Fisher, R. S., Elbaum‐Garfinkle, S., & Obermeyer, A. C. (2022) · Chemical Science · doi:10.1039/d2sc00192f · Cited by 11
Gene Editing in Ganoderma lucidum: Development, Challenges, and Future Prospects
He, S., Liu, Y., Zhang, Z., Cai, M., Hao, Y., & Hu, H. (2025) · Journal of Fungi · doi:10.3390/jof11040310 · Cited by 11
Development and challenges of using CRISPR-Cas9 system in mammalians
Khambhati, K., Gohil, N., Bhattacharjee, G., & Singh, V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818140-9.00007-6 · Cited by 10
Delivery Methods, Resources and Design Tools in CRISPR/Cas
Aslam, M. A., Hammad, M., Ahmad, A., Altenbuchner, J., & Ali, H. (2021) · Springer eBooks · doi:10.1007/978-981-15-7142-8_3 · Cited by 10
Progression and application of CRISPR-Cas genomic editors
Yang, L., Tang, J., Ma, X., Lin, Y., Ma, G., Shan, M., Wang, L., & Yang, Y. (2021) · Methods · doi:10.1016/j.ymeth.2021.03.013 · Cited by 10
CRISPA: A Non-viral, Transient Cas9 Delivery System Based on Reengineered Anthrax Toxin
Hirschenberger, M., Stadler, N., Fellermann, M., Sparrer, K. M. J., Kirchhoff, F., Barth, H., & Papatheodorou, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.770283 · Cited by 10
Deubiquitinase USP19 enhances phenylalanine hydroxylase protein stability and its enzymatic activity
Sarodaya, N., Tyagi, A., Kim, H., Colaco, J. C., Kang, J., Kim, W. J., Kim, K.-S., & Ramakrishna, S. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09719-z · Cited by 10
Self-citationHeterologous Naringenin Production in the Filamentous Fungus Penicillium rubens
Peng, B., Dai, L., Iacovelli, R., Driessen, A. J. M., & Haslinger, K. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c06755 · Cited by 10
CRISPR/Cas9: The Leading Edge of Genome Editing Technology
Sakuma, T., & Yamamoto, T. (2014) · Springer eBooks · doi:10.1007/978-4-431-55227-7_2 · Cited by 10
Sumer, S., Hoffmann, S., Laue, S., Campbell, B., Rädecke, K., Frajs, V., Clauß, S., Kääb, S., Janssen, J. W. G., Jauch, A. S., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.08.015 · Cited by 10
Integrating Biomaterials and Genome Editing Approaches to Advance Biomedical Science
Abdeen, A. A., Cosgrove, B. D., Gersbach, C. A., & Saha, K. (2021) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-122019-121602 · Cited by 11
Transgene-free genome editing and RNAi ectopic application in fruit trees: Potential and limitations
Gouthu, S., Mandelli, C., Eubanks, B. A., & Deluc, L. G. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.979742 · Cited by 12
Solid-phase reverse transfection for intracellular delivery of functionally active proteinsPreprint
Bulkescher, R., Starkuviene, V., & Erfle, H. (2017) · Genome Research · doi:10.1101/gr.215103.116 · Cited by 10
Genome editing in mice and its application to the study of spermatogenesis
Oura, S., Mori, H., & Ikawa, M. (2022) · Gene and Genome Editing · doi:10.1016/j.ggedit.2022.100014 · Cited by 9
Advances in Cytosolic Delivery of Proteins: Approaches, Challenges, and Emerging Technologies
Zhang, W., Liu, H., Zhu, B., Li, W., Han, X., Fu, J., Luo, R., Wang, H., & Wang, J. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202401713 · Cited by 10
Therapeutic Application of mRNA for Genetic Diseases
Schürmann, P. J. L., Vriesman, S. V. B., Castro-Alpízar, J., Kooijmans, S. A. A., Nieuwenhuis, E. E. S., Schiffelers, R. M., & Fuchs, S. A. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70019 · Cited by 9
Gustafsson, O., Krishna, S., Borate, S., Ghaeidamini, M., Liang, X., Saher, O., Cuellar, R., Birdsong, B. K., Roudi, S., Estupiñan, H. Y., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114038 · Cited by 11
Rapaka, H., Manturthi, S., Arjunan, P., Venkatesan, V., Thangavel, S., Marepally, S. K., & Patri, S. V. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c01226 · Cited by 8
Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e
Zheng, S., Liang, F., Zhang, Y., Fei, J., Qin, W., & Liu, Y. (2023) · Journal of Visualized Experiments · doi:10.3791/64977 · Cited by 9
Mechanisms of the Specificity of the CRISPR/Cas9 System in Genome Editing
Kulishova, L. M., Vokhtantsev, I. P., Kim, D. V., & Zharkov, D. O. (2023) · Molecular Biology · doi:10.1134/s0026893323020139 · Cited by 10
Colaco, J. C., Chandrasekaran, A. P., Karapurkar, J. K., Gowda, D. A. A., Birappa, G., Rajkumar, S., Suresh, B., Ko, N. R., Hong, S., Oh, S. J., et al. (2023) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2023.130454 · Cited by 9
Self-citationEvmenov, K., Pustogarov, N., Panteleev, D. Y., Safin, A., & Alkalaeva, E. Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031622 · Cited by 9
CRISPR-Cas9 Targeting PCSK9: A Promising Therapeutic Approach for Atherosclerosis
Gu, B., Li, M., Li, D., & Huang, K. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-024-10587-7 · Cited by 13
Applications of CPPs in Genome Modulation of Plants
Ziemienowicz, A., Pepper, J. T., & Eudes, F. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2806-4_28 · Cited by 10
Lemoine, A., Friec, G. C.-L., Vives, F. L., & Louvet, C. (2016) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2016.04.004 · Cited by 9
Methods of genome engineering: a new era of molecular biology
Chugunova, A. A., Донцова, О. А., & Владимирович, С. П. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916070038 · Cited by 9
Cas9 conjugate complex delivering donor DNA for efficient gene editing by homology-directed repair
Kang, Y. K., Lee, J. H., Im, S. H., Lee, J. H., Jeong, J., Kim, D. K., Yang, S. Y., Jung, K., Kim, S., & Chung, H. J. (2021) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2021.07.009 · Cited by 9
Bartnicki, F., Bonarek, P., Kowalska, E., & Strzałka, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-02432-6 · Cited by 9
CRISPR-Cas9 System as a Genome Editing Tool in Sugarcane
Augustine, S. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-58946-6_11 · Cited by 11
Paranthaman, S., Uthaiah, C. A., Md, S., & Alkreathy, H. M. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103497 · Cited by 8
Purification of Cas9— RNA complexes by ultrafiltration
Manzano, I., Taylor, N. W., Csordas, M., Vezeau, G. E., Salis, H. M., & Zydney, A. L. (2020) · Biotechnology Progress · doi:10.1002/btpr.3104 · Cited by 8
Sellers, D. L., Lee, K., Murthy, N., & Pun, S. H. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.057 · Cited by 8
Lipid‐, Inorganic‐, Polymer‐, and DNA‐Based Nanocarriers for Delivery of the CRISPR/Cas9 system
Song, N., Chu, Y., Tang, J., & Yang, D. (2023) · ChemBioChem · doi:10.1002/cbic.202300180 · Cited by 9
Luo, M., Ma, J., Cheng, X., Wu, S., Bartels, D., Guay, D. R. P., Engelhardt, J. F., & Liu, X. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.016 · Cited by 8
Epigenetic editing for autosomal dominant neurological disorders
Waldo, J. J., Halmai, J. A. N. M., & Fink, K. D. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1304110 · Cited by 8
dCas9 Tells Tales: Probing Gene Function and Transcription Regulation in Cancer
Zamberi, N. N. M., Abuhamad, A. Y., Low, T. Y., Mohtar, M. A., & Syafruddin, S. E. (2024) · The CRISPR Journal · doi:10.1089/crispr.2023.0078 · Cited by 9
Recent advances in CRISPR-Cas systems for colorectal cancer research and therapeutics
Sokhangouy, S. K., Alizadeh, F. L., Lotfi, M., Sharif, S., Ashouri, A., Yoosefi, Y., Qomi, S. B., & Abbaszadegan, M. R. (2024) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2024.2388777 · Cited by 8
Sakuma, T., Mochida, K., Nakade, S., Ezure, T., Minagawa, S., & Yamamoto, T. (2018) · Genes to Cells · doi:10.1111/gtc.12569 · Cited by 8
A Modified Monomeric Red Fluorescent Protein Reporter for Assessing CRISPR Activity
Knudsen, C. H., Ásgrímsdóttir, E. S., Rahimi, K., Gill, K. P., Frandsen, S., Buchholdt, S. H., Chen, M., Kjems, J., Febbraro, F., & Denham, M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00054 · Cited by 7
Frontiers of CRISPR-Cas9 for Cancer Research and Therapy
Banerjee, A., Malonia, S. K., & Dutta, S. (2021) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2020.00033 · Cited by 9
Gene Delivery into Cells and Tissues
Duvall, C. L., Prokop, A., Gersbach, C. A., & Davidson, J. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398358-9.00035-5 · Cited by 8
Using Genome Engineering to Understand Huntington’s Disease
Bailus, B. J., Zhang, N., & Ellerby, L. (2017) · Research and perspectives in neurosciences · doi:10.1007/978-3-319-60192-2_9 · Cited by 8
Truncated gRNA reduces CRISPR/Cas9-mediated off-target rate for MSTN gene knockout in bovines
Zhou, Z., Guo-hua, C. A. O., Li, Z., Han, X., Li, C., Lu, Z., Zhao, Y., & Li, X. (2019) · Journal of Integrative Agriculture · doi:10.1016/s2095-3119(19)62744-9 · Cited by 8
In vivo direct cell-penetrating peptide mediated protein transduction system in Acyrthosiphon pisum
Takenaka, A., Konno, H., & Kikuta, S. (2023) · BMC Research Notes · doi:10.1186/s13104-023-06514-9 · Cited by 7
Ghosh, A., Riester, M., Pal, J., Lainde, K.-A., Tangermann, C., Wanninger, A., Dueren, U. K., Dhamija, S., & Diederichs, S. (2024) · Nature Communications · doi:10.1038/s41467-024-52779-4 · Cited by 7
Zhong, J., Kang, J.-L., Wang, X., Jiang, W., Liao, H., & Jin, Y. (2015) · Medical Oncology · doi:10.1007/s12032-015-0495-0 · Cited by 7
Singpant, P., Tubsuwan, A., Sakdee, S., Ketterman, A. J., Jearawiriyapaisarn, N., Kurita, R., Nakamura, Y., Songdej, D., Tangprasittipap, A., Bhukhai, K., et al. (2023) · Protein Expression and Purification · doi:10.1016/j.pep.2023.106313 · Cited by 7
Genome Editing in Mice Using CRISPR/Cas9: Achievements and Prospects
Delerue, F. (2015) · Cloning & Transgenesis · doi:10.4172/2168-9849.1000135 · Cited by 8
Enhanced gene disruption by programmable nucleases delivered by a minicircle vector
Dad, A.-B., Ramakrishna, S., Song, M., & Kim, S. (2014) · Gene Therapy · doi:10.1038/gt.2014.76 · Cited by 7
Self-citationAdvances in Research on Down Syndrome
Dey, S. (2018) · InTech eBooks · doi:10.5772/intechopen.68260 · Cited by 7
Modulating Cas9 activity for precision gene editing
Uslu, M., Si̇yah, P., Harvey, A. J., & Kocabaş, F. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.015 · Cited by 7
A Computational Investigation of In Vivo Cytosolic Protein Delivery for Cancer Therapy
Torres, C., Dumas, S., Palacio-Castañeda, V., Descroix, S., Brock, R. E., & Verdurmen, W. P. R. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040562 · Cited by 7
CRISPR/Cas9 Plasmid Delivery Through the CPP: PepFect14
Falato, L., Vunk, B., & Langel, Ü. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1752-6_38 · Cited by 7
CRISPR off-target analysis platforms
Xu, C. L., Ruan, M. Z., Ragi, S. D., & Tsang, S. H. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2651-1_26 · Cited by 6
Vázquez-Domínguez, I., Öktem, M., Winkelaar, F. A., Nguyen, T. H., Hoogendoorn, A. D. M., Roschi, E., Astuti, G., Timmermans, R., Suárez-Herrera, N., Bruno, I., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102345 · Cited by 7
Thevendran, R., & Solayappan, M. (2023) · Biotechnology Journal · doi:10.1002/biot.202300077 · Cited by 6
Advances in CRISPR/Cas systems-based cell and gene therapy
Poddar, A., Ahmady, F., Prithviraj, P., Luwor, R. B., Shukla, R., Polash, S. A., Li, H., Ramakrishna, S., Kannourakis, G., & Jayachandran, A. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.07.005 · Cited by 6
Self-citationDevelopment and use of CRISPR in industrial applications
Abdelaal, A. S., & Yazdani, S. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818140-9.00016-7 · Cited by 6
Metadata
- Authors
- Ramakrishna, S., Kwaku Dad, A.-B., Beloor, J., Gopalappa, R., Lee, S.-K., & Kim, H.
- Affiliations
- Hanyang University (KR)
- Venue
- Genome Research
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2014-04-02
- Volume
- 24
- Issue
- 6
- Pages
- 1020-1027
- ISSN
- 1088-9051 (ISSN-L)
- PMC
- PMC4032848
- OpenAlex
- W2103609218
- Cited by
- 655
- References
- 45
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 41 · 2023: 46 · 2022: 64 · 2021: 76 · 2020: 66 · 2019: 60 · 2018: 77 · 2017: 60 · 2016: 56 · 2015: 50 · 2014: 11
- Type
- posted content
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Genome Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Research Foundation
- Hanyang University
- Yonsei University
- Korea Basic Science Institute
- National Research Foundation of Korea (2013M3A9B4076544, 2011‐0019357)
- Korea Advanced Institute of Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, cell-penetrating peptides, gene disruption, genome editing, guide RNA delivery, off-target mutations, embryonic stem cells, human cell lines
- MeSH terms
- RNA, Guide, CRISPR-Cas Systems, Humans, Transfection, Genome, Human, Mutagenesis, Site-Directed, RNA Editing, RNA, Guide, Kinetoplastida, Cell Line, Tumor, Nanoparticles, HEK293 Cells, Cell-Penetrating Peptides, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
